DOCSLIB.ORG

The Kidneys in Inflammatory Bowel Disease

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Kidneys in Inflammatory Bowel Disease ANNALS OF GASTROENTEROLOGY 2002, 15(1):41-52 Review The kidneys in inflammatory bowel disease K.H. Katsanos1, E.V. Tsianos2 SUMMARY bowel surgery include ureteral injury, urinary vetention and sexual dysfunction. Extraintestinal manifestations and complications are com- mon in patients with inflammatory bowel disease (IBD) and Key words: renal, urinary, genital, drugs, therapy, inflam- may involve almost any organ or system. Renal or urinary matory bowel disease, Crohns, ulcerative colitis, glomeru- complications occur in 4-23% of patients often in those with lar, tubular, interstitial, kidneys. severe long-standing disease. The most common manifes- tations are kidney stones, enterovesical fistulas and ure- 1. EPIDEMIOLOGY teral obstruction. Genital involvement is uncommon in IBD. Patients with IBD have a risk of nephrolithiasis 10-100 Extraintestinal manifestations and complications are times greater than that for the general hospital population. common in patients with inflammatory bowel disease Glomerulonephritis (GN) in IBD has been reported in at (IBD) and can involve almost any organ or system. Re- least 27 patients; of these 7 had CD, 17 had UC and 3 were nal or urinary complications occur in 4-23% of patients, indeterminate.Histology changes range from minimal often in those with severe long-standing disease (Tables change nephropathy to rapidly progressive crescentic GN 1, 2). The most common manifestations are kidney stones, which may be accompanied by active tubulointerstitial ne- enterovesical fistulas and ureteral obstruction1. Fistulas phritis. Tubulointerstitial abnormalities are not uncom- between the gastrointestinal tract and the urinary sys- mon in autopsy studies of IBD patients. Granulomatous tem are uncommon, occuring in 1-8%, being more com- interstitial nephritis, interstitial nephritis with hyper- mon in patients with ileal or ileocecal disease than in oxalouria and renal tubular acidosis have also been report- those with colonic disease. Ureteral obstruction is not ed. Inflammatory bowel disease is an uncommon cause of caused by stones in 50-73% of cases of CD and in 50% of secondary amyloidosis. Complications from medical ther- cases of UC2. This non-calculus obstruction (NCO) is on apy are relatively rare in the majority of drugs used to treat the right in the great majority of patients. Genital in- IBD. There is little or no nephrotoxicity with many drugs used including corticosteroids, azathioprine or 6-mercap- topurine, metronidazole and low dose methotrexate. The Table 1. Renal complications in IBD drugs with significant potential renal toxicity are the ami- 1. Glomerulonephritis (from minimal change nephropathy to nosalicylates (sulfasalazine, mesalamine, 5-ASA, olsala- rapidly progressive crescentic GN) zine) and cyclosporine. Surgical complications following 2. Tubulointerstitial abnormalities (interstitial nephritis, gra- noulomatous interstitial nephritis, nephrocalcinosis, renal tubulor acidosis) 1House Officer in Gastroenterology, 2Professor of Medicine, Department of Internal Medicine, Hepato-Gastroenterology Unit, 3. Amyloidosis Medical School, University of Ioannina, Greece 4. Renal hypertension 5. Iatrogenic complications: medications, aminosalicylates, Author for correspondence: cyclosporine, xylitol at high dose, sodium phosphate (co- Dr Epameinondas V. Tsianos, Professor of Medicine, Department lon cleansing) of Internal Medicine, Medical School, University of Ioannina, 6. Miscellaneous complications Greece, PC 45 500 Ioannina, Fax/phone:++30-651-99736, e-mail: [email protected] 7. Pyonephrosis/Pyelonephritis 42 K.H. KATSANOS, et al Table 2. Urologic complications in IBD tory bowel disease is an uncommon cause of secondary 1. Fistulas amyloidosis. Only a few dozen with CD have been re- - enterovesical ported with amyloidosis, the association with UC being 2 - rectovesical even less common . The reported prevalence of second- ary amyloidosis in IBD patients varies from 0,5-29% in - rectourethral CD and from 0-0,4% in UC with a lower prevalence clin- - anourethral ically and a higher prevalence at autopsy5. Complications - urethrocutaneous from medical therapy are relatively rare in the majority - vesicocutaneous of drugs used to treat IBD. There is little or no nephro- - ileoureteral toxicity with many drugs used including corticosteroids, - enterourachovesical azathioprine or 6-mercaptopurine, metronidazole and - ileal pouch-vesical low dose methotrexate. The drugs with significant po- 2. Acute/chronic pyelonephritis tential renal toxicity are the aminosalicylates (sulfasala- 3. Nephrolithiasis (uric acid, calcium oxalate, calcium phos- zine, mesalamine, 5-ASA, olsalazine) and cyclosporine. phate) Surgical complications following bowel surgery include 6 4. Non calculous obstructive uropathy ureteral injury, urinary vetention and sexual dysfunction . 5. Genital involvement (penis, scrotum, vulva, prostate gland) These are uncommon according to some studies where- as higher rates are reported in others, particularly with 6. Iatrogenic complications (Surgical complications) proctocolectomy7. There are reports of various genitouri- 7. Miscellaneous complications nary malignancies in IBD patients, inclunding renal cell, bladder, prostate and vulvar carcinoma. However, two large studies found no increased risk of renal or urinary volvement is uncommon in IBD. Patients with IBD have malignancies in IBD patients8,9. a risk of nephrolithiasis 10-100 times greater than that for the general hospital population. The risk is higher in adults than children and in patients with CD compared 2. IMMUNOLOGY with UC Kidney stones in IBD are composed primarily A study of 13 patients diagnosed with ulcerative col- of calcium oxalate or uric acid (Table 3). Glomerulone- itis was conducted to determine whether the presence of phritis (GN) in IBD has been reported in at least 27 pa- ANCA in those patients is associated with renal pathol- tients; of these 7 had CD, 17 had UC and 3 were indeter- ogy10. Renal damage was not observed in ANCA-posi- minate. Histology changes range from minimal change tive patients with colitis even after 1 year of follow up, nephropathy to rapidly progressive crescentic GN and suggesting that the ANCA found in these patients did may be accompanied by active tubulointerstitial nephri- not share the antigenic targets with the ANCA commonly 3 tis . Tubulointerstitial abnormalities are not uncommon found in renal vasculitis11. Therefore the potential of in autopsy studies of IBD patients. Tubular degenera- ANCA of inducing renal lesions (if any) is dependent on tion was seen in 31% of CD and in 23% of UC patients their own antigenic specificity. As far as anti-brush bor- who were not on ASA. Granulomatous interstitial ne- der antibodies (ABBA) are concerned, seventy-four se- phritis, interstitial nephritis with hyperoxalouria and re- rum samples from patients with Crohns disease were an- 4 nal tubular acidosis have also been reported . Inflamma- alysed for the presence of antibodies against various tis- sue antigens12. With indirect immunofluorescence micro- scopy, 61% of the patient sera were shown to possess Table 3. Stone types and pathophysiology in IBD (Adopted from reference 2) antibodies (in a titre of 1:25 or more) reacting with rat brush border membrane antigens in the proximal tubules Stone type Risk factors of the kidneys, in the gastric parietal cells, and in the 1. Uric acid Diarrhea, ileostomy, hyperurichemia bile canaliculi of the liver. Serum samples submitted for 2. Calcium oxalate Ileal resection or disease,enteric routine immunofluorescence antibody screening served hyperoxaluria as controls; 10% of these sera contained anti-brush bor- 3. Calcium phosphate Bed rest, steroids,increased urine Ca der anti-bodies. There is also an antigenic relationship (mobilization from bone and de between human kidney, colon and the common antigen creased ubularresorption of Ca) of enterobacteriaceal13,14. IGF system and IBD 43 3.ANIMAL MODELS OF IBD infusion24. A renographic monitoring of the renal func- NEPHROTOXICITY tion with Hippuran in patients with Crohns disease treat- ed with low dose was cyclosporin was proposed in a con- In cats the diagnosis of cholangiohepatitis should be trolled study where a correlation has been found between further evaluated for IBD and pancreatitis but there is the residual activity 20 minutes after the injection and no indication to search for nephritis15. Rabbits which were the degree of intertitial fibrosis seen in renal biopsies25. immunized with intestinal antigens derived from rabbits, guinea pigs, and germ-free rats revealed interstitial ne- phritis16. These changes did not occur when non-intesti- 5. OTHER ASSOCIATIONS WITH IBD RENAL nal antigens were used for immunization. In rats the use INVOLVEMENT of hyperosmolar enemas can induce nephritis throughout Inflammatory bowel disease and IBD-related renal massive acidosis and electrolyte disturbances with hypoc- involvement can coexist with other organ or system de- alcemia and hypernatremia. Consequently, sodium phos- teriorations or disease. The rare triad sclerosing cholan- phate solutions should probably not be used in patients gitis, IBD and gromerulonephritis has twice been re- with inflammatory bowel disease with a high risk of lac- ported26. Also nonspecific ulcerative rectocolitis and eration of the mucosa or perforation of the bowel or di- lupus erythrematosus with renal involvement has been rect toxic effect on kidneys17,18. E 3040, a new class of anti-flammatory drug used
Load more

Recommended publications
  • PATHOLOGY of the RENAL SYSTEM”, I Hope You Guys Like It 
    ﺑﺴﻢ اﷲ اﻟﺮﺣﻤﻦ اﻟﺮﺣﯿﻢ ھﺬه اﻟﻤﺬﻛﺮة ﻋﺒﺎرة ﻋﻦ إﻋﺎدة ﺗﻨﺴﯿﻖ وإﺿﺎﻓﺔ ﻧﻮﺗﺎت وﻣﻮاﺿﯿﻊ ﻟﻤﺬﻛﺮة زﻣﻼﺋﻨﺎ ﻣﻦ اﻟﺪﻓﻌﺔ اﻟﺴﺎﺑﻘﺔ ٤٢٧ اﻷﻋﺰاء.. ﻟﺘﺘﻮاﻓﻖ ﻣﻊ اﻟﻤﻨﮭﺞ اﻟﻤﻘﺮر ﻣﻦ اﻟﻘﺴﻢ ﺣﺮﺻﻨﺎ ﻓﯿﮭﺎ ﻋﻠﻰ إﻋﺎدة ﺻﯿﺎﻏﺔ ﻛﺜﯿﺮ ﻣﻦ اﻟﺠﻤﻞ ﻟﺘﻜﻮن ﺳﮭﻠﺔ اﻟﻔﮭﻢ وﺳﻠﺴﺔ إن ﺷﺎء اﷲ.. وﺿﻔﻨﺎ ﺑﻌﺾ اﻟﻨﻮﺗﺎت اﻟﻤﮭﻤﺔ وأﺿﻔﻨﺎ ﻣﻮاﺿﯿﻊ ﻣﻮﺟﻮدة ﺑﺎﻟـ curriculum ﺗﻌﺪﯾﻞ ٤٢٨ ﻋﻠﻰ اﻟﻤﺬﻛﺮة ﺑﻮاﺳﻄﺔ اﺧﻮاﻧﻜﻢ: ﻓﺎرس اﻟﻌﺒﺪي ﺑﻼل ﻣﺮوة ﻣﺤﻤﺪ اﻟﺼﻮﯾﺎن أﺣﻤﺪ اﻟﺴﯿﺪ ﺣﺴﻦ اﻟﻌﻨﺰي ﻧﺘﻤﻨﻰ ﻣﻨﮭﺎ اﻟﻔﺎﺋﺪة ﻗﺪر اﻟﻤﺴﺘﻄﺎع، وﻻ ﺗﻨﺴﻮﻧﺎ ﻣﻦ دﻋﻮاﺗﻜﻢ ! 2 After hours, or maybe days, of working hard, WE “THE PATHOLOGY TEAM” are proud to present “PATHOLOGY OF THE RENAL SYSTEM”, I hope you guys like it . Plz give us your prayers. Credits: 1st part = written by Assem “ THe AWesOme” KAlAnTAn revised by A.Z.K 2nd part = written by TMA revised by A.Z.K د.ﺧﺎﻟﺪ اﻟﻘﺮﻧﻲ 3rd part = written by Abo Malik revised by 4th part = written by A.Z.K revised by Assem “ THe AWesOme” KAlAnTAn 5th part = written by The Dude revised by TMA figures were provided by A.Z.K Page styling and figure embedding by: If u find any error, or u want to share any idea then plz, feel free to msg me [email protected] 3 Table of Contents Topic page THE NEPHROTIC SYNDROME 4 Minimal Change Disease 5 MEMBRANOUS GLOMERULONEPHRITIS 7 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 9 MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS 11 DIABETIC NEPHROPATHY (new) 14 NEPHRITIC SYNDROME 18 Acute Post-infectious GN 19 IgA Nephropathy (Berger Disease) 20 Crescentic GN 22 Chronic GN 24 SLE Nephropathy (new) 26 Allograft rejection of the transplanted kidney (new) 27 Urinary Tract OBSTRUCTION, 28 RENAL STONES 23 HYDRONEPHROSIS
    [Show full text]
  • Inherited Renal Tubulopathies—Challenges and Controversies
    G C A T T A C G G C A T genes Review Inherited Renal Tubulopathies—Challenges and Controversies Daniela Iancu 1,* and Emma Ashton 2 1 UCL-Centre for Nephrology, Royal Free Campus, University College London, Rowland Hill Street, London NW3 2PF, UK 2 Rare & Inherited Disease Laboratory, London North Genomic Laboratory Hub, Great Ormond Street Hospital for Children National Health Service Foundation Trust, Levels 4-6 Barclay House 37, Queen Square, London WC1N 3BH, UK; [email protected] * Correspondence: [email protected]; Tel.: +44-2381204172; Fax: +44-020-74726476 Received: 11 February 2020; Accepted: 29 February 2020; Published: 5 March 2020 Abstract: Electrolyte homeostasis is maintained by the kidney through a complex transport function mostly performed by specialized proteins distributed along the renal tubules. Pathogenic variants in the genes encoding these proteins impair this function and have consequences on the whole organism. Establishing a genetic diagnosis in patients with renal tubular dysfunction is a challenging task given the genetic and phenotypic heterogeneity, functional characteristics of the genes involved and the number of yet unknown causes. Part of these difficulties can be overcome by gathering large patient cohorts and applying high-throughput sequencing techniques combined with experimental work to prove functional impact. This approach has led to the identification of a number of genes but also generated controversies about proper interpretation of variants. In this article, we will highlight these challenges and controversies. Keywords: inherited tubulopathies; next generation sequencing; genetic heterogeneity; variant classification. 1. Introduction Mutations in genes that encode transporter proteins in the renal tubule alter kidney capacity to maintain homeostasis and cause diseases recognized under the generic name of inherited tubulopathies.
    [Show full text]
  • RENAL BIOPSY and GLOMERULONEPHRITIS by J
    Postgrad Med J: first published as 10.1136/pgmj.35.409.604 on 1 November 1959. Downloaded from 604 RENAL BIOPSY AND GLOMERULONEPHRITIS By J. H. Ross, M.D., M.R.C.P. Senior Medical Registrar, The Connaught Hospital, and Assistant, The Mledical Unit, The London Hospital Introduction sufficient to establish a diagnosis in a few condi- Safe methods of percutaneous renal biopsy were tions such as amyloid disease and diabetic first described by Perez Ara (1950) and Iversen glomerulosclerosis, but cortex with at least io and Brun (I95I) who used aspiration techniques. glomeruli is necessary for an accurate assessment Many different methods have since been described; of the renal structure; occasionally, up to 40 the simplest is that of Kark and Muehrcke (1954) glomeruli may be present in a single specimen. who use the Franklin modification of the Vim- The revelation of gross structural changes in Silverman needle. the kidneys of patients who can be recognized Brun and Raaschou (1958) have recently re- clinically as having chronic glomerulonephritis is viewed the majority of publications concerned of little value and does not contribute to manage- with renal biopsy and have concluded that the risk ment or prognosis. In contrast, biopsy specimensProtected by copyright. to the patients is slight. They mentioned three from patients in the early stages of glomerulo- fatalities which have been reported but considered nephritis, particularly those who have developed that, in each case, death was probably due to the the nephrotic syndrome insidiously without disease process rather than the investigation. haematuria or renal failure or who showy no Retroperitoneal haematomata have been recorded evidence of disease other than proteinuria, may in patients with hypertension or uraemia but are provide useful information.
    [Show full text]
  • Effects of Ramipril in Nondiabetic Nephropathy: Improved Parameters of Oxidatives Stress and Potential Modulation of Advanced Glycation End Products
    Journal of Human Hypertension (2003) 17, 265–270 & 2003 Nature Publishing Group All rights reserved 0950-9240/03 $25.00 www.nature.com/jhh ORIGINAL ARITICLE Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products KSˇ ebekova´1, K Gazdı´kova´1, D Syrova´2, P Blazˇı´cˇek2, R Schinzel3, A Heidland3, V Spustova´1 and R Dzu´ rik 1Institute of Preventive and Clinical Medicine, Bratislava, Slovakia; 2Military Hospital, Bratislava, Slovakia; 3University Wuerzburg, Germany Enhanced oxidative stress is involved in the progres- patients on conventional therapy did not differ signifi- sion of renal disease. Since angiotensin converting cantly from the ramipril group, except for higher Hcy enzyme inhibitors (ACEI) have been shown to improve levels in the latter. Administration of ramipril resulted in the antioxidative defence, we investigated, in patients a drop in blood pressure and proteinuria, while creati- with nondiabetic nephropathy, the short-term effect of nine clearance remained the same. The fluorescent the ACEI ramipril on parameters of oxidative stress, AGEs exhibited a mild but significant decline, yet CML such as advanced glycation end products (AGEs), concentration was unchanged. The AOPP and malon- advanced oxidation protein products (AOPPs), homo- dialdehyde concentrations decreased, while a small rise cysteine (Hcy), and lipid peroxidation products. Ramipril in neopterin levels was evident after treatment. The (2.5–5.0 mg/day) was administered to 12 newly diag- mentioned parameters were not affected significantly in nosed patients for 2 months and data compared with a the conventionally treated patients. Evidence that rami- patient group under conventional therapy (diuretic/ pril administration results in a mild decline of fluores- b-blockers) and with age- and sex-matched healthy cent AGEs is herein presented for the first time.
    [Show full text]
  • Guidelines on Urolithiasis
    Guidelines on Urolithiasis C. Türk (chair), T. Knoll (vice-chair), A. Petrik, K. Sarica, A. Skolarikos, M. Straub, C. Seitz © European Association of Urology 2014 TABLE OF CONTENTS PAGE 1. METHODOLOGY 7 1.1 Introduction 7 1.2 Data identification 7 1.3 Evidence sources 7 1.4 Level of evidence and grade of recommendation 7 1.5 Publication history 8 1.5.2 Potential conflict of interest statement 8 1.6 References 8 2. CLASSIFICATION OF STONES 9 2.1 Stone size 9 2.2 Stone location 9 2.3 X-ray characteristics 9 2.4 Aetiology of stone formation 9 2.5 Stone composition 9 2.6 Risk groups for stone formation 10 2.7 References 11 3. DIAGNOSIS 12 3.1 Diagnostic imaging 12 3.1.1 Evaluation of patients with acute flank pain 12 3.1.2 Evaluation of patients for whom further treatment of renal stones is planned 13 3.1.3 References 13 3.2 Diagnostics - metabolism-related 14 3.2.1 Basic laboratory analysis - non-emergency urolithiasis patients 15 3.2.2 Analysis of stone composition 15 3.3 References 16 4. TREATMENT OF PATIENTS WITH RENAL COLIC 16 4.1 Renal colic 16 4.1.1 Pain relief 16 4.1.2 Prevention of recurrent renal colic 16 4.1.3 Recommendations for analgesia during renal colic 17 4.1.4 References 17 4.2 Management of sepsis in obstructed kidney 18 4.2.1 Decompression 18 4.2.2 Further measures 18 4.2.3 References 18 5. STONE RELIEF 19 5.1 Observation of ureteral stones 19 5.1.1 Stone-passage rates 19 5.2 Observation of kidney stones 19 5.3 Medical expulsive therapy (MET) 20 5.3.1 Medical agents 20 5.3.2 Factors affecting success of medical expulsive
    [Show full text]
  • April 2020 Radar Diagnoses and Cohorts the Following Table Shows
    RaDaR Diagnoses and Cohorts The following table shows which cohort to enter each patient into on RaDaR Diagnosis RaDaR Cohort Adenine Phosphoribosyltransferase Deficiency (APRT-D) APRT Deficiency AH amyloidosis MGRS AHL amyloidosis MGRS AL amyloidosis MGRS Alport Syndrome Carrier - Female heterozygote for X-linked Alport Alport Syndrome (COL4A5) Alport Syndrome Carrier - Heterozygote for autosomal Alport Alport Syndrome (COL4A3, COL4A4) Alport Syndrome Alport Anti-Glomerular Basement Membrane Disease (Goodpastures) Vasculitis Atypical Haemolytic Uraemic Syndrome (aHUS) aHUS Autoimmune distal renal tubular acidosis Tubulopathy Autosomal recessive distal renal tubular acidosis Tubulopathy Autosomal recessive proximal renal tubular acidosis Tubulopathy Autosomal Dominant Polycystic Kidney Disease (ARPKD) ADPKD Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) ADTKD Autosomal Recessive Polycystic Kidney Disease (ARPKD) ARPKD/NPHP Bartters Syndrome Tubulopathy BK Nephropathy BK Nephropathy C3 Glomerulopathy MPGN C3 glomerulonephritis with monoclonal gammopathy MGRS Calciphylaxis Calciphylaxis Crystalglobulinaemia MGRS Crystal-storing histiocytosis MGRS Cystinosis Cystinosis Cystinuria Cystinuria Dense Deposit Disease (DDD) MPGN Dent Disease Dent & Lowe Denys-Drash Syndrome INS Dominant hypophosphatemia with nephrolithiasis or osteoporosis Tubulopathy Drug induced Fanconi syndrome Tubulopathy Drug induced hypomagnesemia Tubulopathy Drug induced Nephrogenic Diabetes Insipidus Tubulopathy Epilepsy, Ataxia, Sensorineural deafness, Tubulopathy
    [Show full text]
  • Guidelines on Urolithiasis
    GUIDELINES ON UROLITHIASIS (Text update April 2010) Ch. Türk (chairman), T. Knoll (vice-chairman), A. Petrik, K. Sarica, C. Seitz, M. Straub, O. Traxer Eur Urol 2001 Oct;40(4):362-71 Eur Urol 2007 Dec;52(6):1610-31 J Urol 2007 Dec;178(6):2418-34 Methodology This update is based on the 2008 version of the Urolithiasis guidelines produced by the former guidelines panel. Literature searches were carried out in Medline and Embase for ran- domised control trials and systematic reviews published between January 1st, 2008, and November 30, 2009, and sig- nificant differences in diagnosis and treatment or in evidence level were considered. Introduction Urinary stone disease continues to occupy an important place in everyday urological practice. The average lifetime risk of stone formation has been reported in the range of 5-10%. Recurrent stone formation is a common problem with all types of stones and therefore an important part of the medical care of patients with stone disease. Classification and Risk Factors Different categories of stone formers can be identified based Urolithiasis 251 on the chemical composition of the stone and the severity of the disease (Table 1). Special attention must be given to those patients who are at high risk of recurrent stone formation (Table 2). Table 1: Categories of stone formers Stone composition Category Non-calcium Infection stones: INF stones Magnesium ammonium phosphate Ammonium urate Uric acid UR Sodium urate Cystine CY Calcium First time stone former, without residual So stones stone or stone fragments. First time stone former, with residual Sres stone or stone fragments.
    [Show full text]
  • Path Renal Outline
    Path Renal Outline Krane’s Categorization of Disease + A lot of Extras Kidney Disease Acute Renal Failure Intrinsic Kidney Disease Pre‐Renal Renal Intrinsic Post‐Renal Sodium Excretion <1% Glomerular Disease Tubulointerstitial Disease Sodium Excretion < 1% Sodium Excretion >2% Labs aren’t that useful BUN/Creatinine > 20 BUN/Creatinine < 10 CHF, Cirrhosis, Edema Urinalysis: Proteinuria + Hematuria Benign Proteinuria Spot Test Ratio >1.5, Spot Test Ratio <1.5, Acute Tubular Acute Interstitial Acute 24 Urine contains > 2.0g/24hrs 24 Urine contains < 1.0g/24hrs Necrosis Nephritis Glomerulonephritis Nephrotic Syndrome Nephritic Syndrome Inability to concentrate Urine RBC Casts Dirty Brown Casts Inability to secrete acid >3.5g protein / 24 hrs (huge proteinuria) Hematuria and Proteinuria (<3.5) Sodium Excretion >2% Edema Hypoalbuminemia RBC Casts Hypercholesterolemia Leukocytes Salt and Water Retention = HTN Focal Tubular Necrosis Edema Reduced GFR Pyelonephritis Minimal change disease Allergic Interstitial Nephritis Acute Proliferative Glomerulonephritis Membranous Glomerulopathy Analgesic Nephropathy Goodpasture’s (a form of RPGN) Focal segmental Glomerulosclerosis Rapidly Progressive Glomerulonephritis Multiple Myeloma Post‐Streptococcal Glomerulonephritis Membranoproliferative Glomerulonephritis IgA nephropathy (MPGN) Type 1 and Type 2 Alport’s Meleg‐Smith’s Hematuria Break Down Hematuria RBCs Only RBC + Crystals RBC + WBC RBC+ Protein Tumor Lithiasis (Stones) Infection Renal Syndrome Imaging Chemical Analysis Culture Renal Biopsy Calcium
    [Show full text]
  • Prime Mover and Key Therapeutic Target in Diabetic Kidney Disease
    Diabetes Volume 66, April 2017 791 Richard E. Gilbert Proximal Tubulopathy: Prime Mover and Key Therapeutic Target in Diabetic Kidney Disease Diabetes 2017;66:791–800 | DOI: 10.2337/db16-0796 The current view of diabetic kidney disease, based on estimated glomerular filtration rate (eGFR) decline (2). In meticulously acquired ultrastructural morphometry and recognition of these findings, the term diabetic kidney the utility of measuring plasma creatinine and urinary al- disease rather than diabetic nephropathy is now commonly bumin, has been almost entirely focused on the glomer- used. On the background of recent advances in the role of ulus. While clearly of great importance, changes in the the proximal tubule as a prime mover in diabetic kidney PERSPECTIVES IN DIABETES glomerulus are not the major determinant of renal prog- pathology, this review highlights key recent developments. nosis in diabetes and may not be the primary event in the Published mostly in the general scientific and kidney- development of diabetic kidney disease either. Indeed, specific literature, these advances highlight the pivotal advances in biomarker discovery and a greater appreci- role this part of the nephron plays in the initiation, pro- ation of tubulointerstitial histopathology and the role of gression, staging, and therapeutic intervention in diabetic tubular hypoxia in the pathogenesis of chronic kidney kidney disease. From a pathogenetic perspective, as illus- disease have given us pause to reconsider the current trated in Fig. 1 and as elaborated on further in this review, “glomerulocentric” paradigm and focus attention on the proximal tubule that by virtue of the high energy require- tubular hypoxia as a consequence of increased energy de- ments and reliance on aerobic metabolism render it par- mands and reduced perfusion combine with nonhypoxia- ticularly susceptible to the derangements of the diabetic related forces to drive the development of tubular atrophy fi state.
    [Show full text]
  • Factors in the Cause of Death in Carcinoma of the Cervix
    FACTORS IN THE CAUSE OF DEATH IN CARCINOMA OF THE CERVIX A STUDY OF FIFTy-SEVEN CASES COMING TO NECROPSY B]ARNE PEARSON, M.D. (Prom the Cancer Institute and De;artment 01 Pathology, University of Minnesota Medkal School, Minneapolis ) This study is based upon 57 consecutive cases of carcinoma Qf the cervix in which autopsy examinations were performed. Thirty-one of these were studied at the University Hospitals. The remaining 26 were taken from the autopsy records in the Department of Pathology at the University of Minne­ sota. Microscopic sections were studied except in a few instances in which they could not be obtained. An attempt has been made to determine the im­ mediate lethal factors and the frequency with which they occur. No attempt is made to determine the efficacy of the treatment. URETERAL STRICTURE Stricture of the ureters with consequent hydronephrosis and hydroureters was the most striking and constant autopsy finding in this series of cases, being present in 42 cases, or 75 per cent. This is in accord with the observations of others. Ernst Holzbach in 4& carcinomas of the cervix coming to autopsy found 31 bilateral and 10 unilateral strictures. Sampson found that the fac­ tors responsible for strictures were external pressure of a mass of carcinoma around the ureters as a result of parametrial extension and lymphatic metasta­ sis, and added infection and edema. Carson states that metastasis may occur to the lymphatics of the ureters. Constriction by metastatic processes was not, however, very common in our series. It occurred only three times and was located in the midportion of the ureter.
    [Show full text]
  • Swiss Consensus Recommendations on Urinary Tract Infections in Children
    European Journal of Pediatrics https://doi.org/10.1007/s00431-020-03714-4 REVIEW Swiss consensus recommendations on urinary tract infections in children Michael Buettcher1 & Johannes Trueck2 & Anita Niederer-Loher3 & Ulrich Heininger4 & Philipp Agyeman5 & Sandra Asner6 & Christoph Berger2 & Julia Bielicki4 & Christian Kahlert3 & Lisa Kottanattu7 & Patrick M. Meyer Sauteur2 & Paolo Paioni2 & Klara Posfay-Barbe8 & Christa Relly2 & Nicole Ritz4 & Petra Zimmermann9 & Franziska Zucol10 & Rita Gobet11 & Sandra Shavit12 & Christoph Rudin 13 & Guido Laube14 & Rodo von Vigier15 & Thomas J. Neuhaus16 Received: 28 July 2019 /Revised: 10 May 2020 /Accepted: 2 June 2020 # The Author(s) 2020, corrected publication 2020 Abstract The kidneys and the urinary tract are a common source of infection in children of all ages, especially infants and young children. The main risk factors for sequelae after urinary tract infections (UTI) are congenital anomalies of the kidney and urinary tract (CAKUT) and bladder-bowel dysfunction. UTI should be considered in every child with fever without a source. The differentiation between upper and lower UTI is crucial for appropriate management. Method of urine collection should be based on age and risk factors. The diagnosis of UTI requires urine analysis and significant growth of a pathogen in culture. Treatment of UTI should be based on practical considerations regarding age and presentation with adjustment of the initial antimicrobial treatment according to antimicrobial sensitivity testing. All children, regard- lessofage,shouldhaveanultrasoundoftheurinarytractperformed
    [Show full text]
  • Silent Hydronephrosis/Pyonephrosis Due to Upper Urinary Tract Calculi in Spinal Cord Injury Patients
    Spinal Cord (2000) 38, 661 ± 668 ã 2000 International Medical Society of Paraplegia All rights reserved 1362 ± 4393/00 $15.00 www.nature.com/sc Silent hydronephrosis/pyonephrosis due to upper urinary tract calculi in spinal cord injury patients S Vaidyanathan*,1, G Singh1, BM Soni1, P Hughes2, JWH Watt1, S Dundas3, P Sett1 and KF Parsons4 1Regional Spinal Injuries Centre, District General Hospital, Southport, Merseyside, UK; 2Department of Radiology, District General Hospital, Southport, Merseyside, UK; 3Department of Cellular Pathology, District General Hospital, Southport, Merseyside, UK; 4Department of Urology, Royal Liverpool University Hospital, Liverpool, UK Study design: A study of four patients with spinal cord injury (SCI) in whom a diagnosis of hydronephrosis or pyonephrosis was delayed since these patients did not manifest the traditional signs and symptoms. Objectives: To learn from these cases as to what steps should be taken to prevent any delay in the diagnosis and treatment of hydronephrosis/pyonephrosis in SCI patients. Setting: Regional Spinal Injuries Centre, Southport, UK. Methods: A retrospective review of cases of hydronephrosis or pyonephrosis due to renal/ ureteric calculus in SCI patients between 1994 and 1999, in whom there was a delay in diagnosis. Results: A T-5 paraplegic patient had two episodes of urinary tract infection (UTI) which were successfully treated with antibiotics. When he developed UTI again, an intravenous urography (IVU) was performed. The IVU revealed a non-visualised kidney and a renal pelvic calculus. In a T-6 paraplegic patient, the classical symptom of ¯ank pain was absent, and the symptoms of sweating and increased spasms were attributed to a syrinx.
    [Show full text]